Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 2 | 004D21A | IM |
shortness of breath; sleep issues; gait/problems walking; experiencing fatigue for years; This spontaneous case was reported by a patient and describes the occurrence of DYSPNOEA (shortness of breath), SLEEP DISORDER (sleep issues), GAIT DISTURBANCE (gait/problems walking) and FATIGUE (experiencing fatigue for years) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004D21A, 006D21A and 066H21A) for COVID-19 prophylaxis. No Medical History information was reported. On 08-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 1 dosage form. On 05-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) dosage was changed to 1 dosage form. On 16-Jan-2022, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (shortness of breath), SLEEP DISORDER (sleep issues), GAIT DISTURBANCE (gait/problems walking) and FATIGUE (experiencing fatigue for years). At the time of the report, DYSPNOEA (shortness of breath), SLEEP DISORDER (sleep issues), GAIT DISTURBANCE (gait/problems walking) and FATIGUE (experiencing fatigue for years) outcome was unknown. No concomitant medication was reported. Patient was inquired regarding the PVS test. Patient shared experiencing multiple side-effects. It was unknown if the patient experienced any additional symptoms/events. No treatment information was reported.